Clinical Trials | December 21, 2025
Soligenix publishes promising Phase 2a data for SGX945 in Behcet's Disease
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
SGX945 delivered beneficial effects in 7 of 8 patients suffering from painful oral ulcers
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
The funding will support the pivotal Phase 3 clinical trial of neridronate in CRPS-1
The move strengthens GBL’s clinical-stage presence in the United States
India plays a critical role in Bristol Myers Squibb’s global strategy
The company operates a chain of mid-sized multi-speciality hospitals
The said certificate is valid for a period of 3 years and opens up the European and other markets for the company's products
The approval of Nuzolvence (zoliflodacin) follows a collaborative development effort with the Global Antibiotic Research and Development Partnership
Dr Srivastava was selected by an expert jury in recognition of her sustained contributions to renewable chemicals, industrial biotechnology and bioprocess innovation
Qfitlia is the first antithrombin (AT)-lowering therapy approved for routine prophylaxis in hemophilia
Subscribe To Our Newsletter & Stay Updated
